Biomarkers play an increasingly important role in drug development where they can facilitate every step within the drug development process and beyond. Development and validation of regulated bioanalytical methods for biomarker determination can pose a multitude of problems, depending on the abundance and number of biomarkers to be monitored, the availability of an appropriate blank matrix, and the complexity of sample preparation.
